Journal of the American Society of Nephrology (JASN) podcast

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

0:00
21:23
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.

Fler avsnitt från "Journal of the American Society of Nephrology (JASN)"